Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform. (2018)

First Author: Gilbert DC
Attributed to:  CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bju.14153

PubMed Identifier: 29388336

Publication URI: http://europepmc.org/abstract/MED/29388336

Type: Journal Article/Review

Volume: 121

Parent Publication: BJU international

Issue: 5

ISSN: 1464-4096